Rx Economic Information-Sharing Concept Getting Renewed Push
Payers join biopharma in seeking clarity around information-sharing provisions in FDAMA Sec. 114 – and in expanding the kind of off-label data that could be disseminated under the law.
Payers join biopharma in seeking clarity around information-sharing provisions in FDAMA Sec. 114 – and in expanding the kind of off-label data that could be disseminated under the law.